BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30967366)

  • 21. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
    Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K
    Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of isolated light chain deposition disease in the duodenum.
    Kim HJ; Park E; Lee TJ; Do JH; Cha YJ; Lee SJ
    J Korean Med Sci; 2012 Feb; 27(2):207-10. PubMed ID: 22323870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses.
    Rostagno A; Frizzera G; Ylagan L; Kumar A; Ghiso J; Gallo G
    Br J Haematol; 2002 Oct; 119(1):62-9. PubMed ID: 12358904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
    Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
    Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathological atlas of renal diseases: light chain deposition disease.
    Ferrario F; Rastaldi MP
    J Nephrol; 2005; 18(5):499-502. PubMed ID: 16299674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
    Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
    Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodular pulmonary light chain deposition disease.
    Yee M; Delahunt B; Russell PA
    Pathology; 2016 Aug; 48(5):515-8. PubMed ID: 27306574
    [No Abstract]   [Full Text] [Related]  

  • 28. Lambda light chain deposition disease in a renal allograft.
    Tanenbaum ND; Howell DN; Middleton JP; Spurney RF
    Transplant Proc; 2005 Dec; 37(10):4289-92. PubMed ID: 16387099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of renal transplantation in light-chain deposition disease.
    Leung N; Lager DJ; Gertz MA; Wilson K; Kanakiriya S; Fervenza FC
    Am J Kidney Dis; 2004 Jan; 43(1):147-53. PubMed ID: 14712438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab?
    Kuypers DR; Lerut E; Claes K; Evenepoel P; Vanrenterghem Y
    Transpl Int; 2007 Apr; 20(4):381-5. PubMed ID: 17326779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary manifestations of light chain deposition disease.
    Rho L; Qiu L; Strauchen JA; Gordon RE; Teirstein AS
    Respirology; 2009 Jul; 14(5):767-70. PubMed ID: 19659654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of surgery of pulmonary cysts related to immunoglobulin light chain deposits].
    Delaey P; Plawny L; Nchimi A; Hirschi S; Weingertner N; Santelmo N; Wirtz G
    Rev Mal Respir; 2020 Feb; 37(2):180-186. PubMed ID: 32014310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nodular pulmonary light chain deposition disease: an entity associated with Sjögren syndrome or marginal zone lymphoma.
    Arrossi AV; Merzianu M; Farver C; Yuan C; Wang SH; Nakashima MO; Cotta CV
    J Clin Pathol; 2016 Jun; 69(6):490-6. PubMed ID: 26502747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies.
    Dasari S; Theis JD; Vrana JA; Meureta OM; Quint PS; Muppa P; Zenka RM; Tschumper RC; Jelinek DF; Davila JI; Sarangi V; Kurtin PJ; Dogan A
    J Proteome Res; 2015 Apr; 14(4):1957-67. PubMed ID: 25734799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary cystic disorder related to light chain deposition disease.
    Colombat M; Stern M; Groussard O; Droz D; Brauner M; Valeyre D; Mal H; Taillé C; Monnet I; Fournier M; Herson S; Danel C
    Am J Respir Crit Care Med; 2006 Apr; 173(7):777-80. PubMed ID: 16399989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal light chain restricted primary intrapulmonary nodular amyloidosis.
    Ross P; Magro CM
    Ann Thorac Surg; 2005 Jul; 80(1):344-7. PubMed ID: 15975406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathomechanisms of cyst formation in pulmonary light chain deposition disease.
    Colombat M; Caudroy S; Lagonotte E; Mal H; Danel C; Stern M; Fournier M; Birembaut P
    Eur Respir J; 2008 Nov; 32(5):1399-403. PubMed ID: 18978139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous Light Chain Deposition Disease: A Report of 2 Cases and Review of the Literature.
    Hendricks C; Fernández Figueras MT; Liersch J; Martin-Urdà MT; López D; Brochhausen C; Röcken C; Schaller J
    Am J Dermatopathol; 2018 May; 40(5):337-341. PubMed ID: 28953013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias.
    Levinson SS
    Clin Chem; 1991 Jun; 37(6):1122-6. PubMed ID: 1904799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.